A worker scans the barcode on the Avifavir antiviral drug approved to treat patients suffering from the coronavirus, at a storage facility at the unknown location, Russia. The Russian Direct Investment Fund (RDIF) and the ChemRar pharmaceutical company said on June 11 they started delivering Avifavir medication against COVID-19 to hospitals across the country. Avifavir, created on the basis of Favipiravir, is one of the two drugs for COVID-19 treatment registered globally. In early June, the Russian Health Ministry said that the medication had proven 90 percent efficient during trials.
- Package: Russia Coronavirus Antiviral Drug
- Categories: Human Interest, Social Issues, Health, Science & Technology
- Location: Russia
- Event date: 10.06.2020
- Date published: 11.06.2020
- Author: Andrey Rudakov
- Source: Russian Direct Investment Fund (RDIF)
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5208x3473px, 13.7Mb
- Job-ID: 6004cdf21f8b347f